Brain organoid studies on the ISS move closer to new treatments
Research using human brain organoids onboard the International Space Station International Space Station (ISS) helped lead to the…
Hollywood star and Bradley Cooper’s ex Jennifer Esposito reveals she was ‘locked in psych ward’
Jennifer Esposito is opening up about the year-long health battle that she says derailed her career, left her…
Multiple sclerosis patients given PBS lifeline amid drug pricing dispute
Life-changing drugs used to treat multiple sclerosis (MS) will remain subsidised for Australians as Labor pledges to resolve…
Novel salvage surgical approach for refractory multiple sclerosis-related trigeminal neuralgia
A case report in Chinese Neurosurgical Journal describes a novel salvage surgical approach for refractory multiple sclerosis-related trigeminal…
Myelin Damage Triggers Abnormal Brain Rhythms During Sleep
Summary: Researchers discovered that when the protective, insulating myelin coating around nerve fibers breaks down, it destabilizes underlying…
PBS dispute could leave MS patients with huge bills for crucial drugs Ocrevus and Kesimpta
A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
Low-cost B-cell depleting therapy is as effective as standard treatment for multiple sclerosis
A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a…
Ocrelizumab slows disability progression in advanced progressive multiple sclerosis
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab…
Preclinical models map genetic changes behind multiple sclerosis nerve damage
More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects…
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
TG Therapeutics, Inc. NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced…
Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus
The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche’s top-selling…
Gut immune responses found to trigger brain inflammation in MS
Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and…